ES480920A1 - Procedimiento para preparar antibioticos de cefalosporina. - Google Patents

Procedimiento para preparar antibioticos de cefalosporina.

Info

Publication number
ES480920A1
ES480920A1 ES480920A ES480920A ES480920A1 ES 480920 A1 ES480920 A1 ES 480920A1 ES 480920 A ES480920 A ES 480920A ES 480920 A ES480920 A ES 480920A ES 480920 A1 ES480920 A1 ES 480920A1
Authority
ES
Spain
Prior art keywords
antibiotics
cefalosporine
translation
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES480920A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES480920A1 publication Critical patent/ES480920A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES480920A 1978-05-26 1979-05-25 Procedimiento para preparar antibioticos de cefalosporina. Expired ES480920A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2291078 1978-05-26
GB2291478 1978-05-26

Publications (1)

Publication Number Publication Date
ES480920A1 true ES480920A1 (es) 1980-02-01

Family

ID=26256188

Family Applications (1)

Application Number Title Priority Date Filing Date
ES480920A Expired ES480920A1 (es) 1978-05-26 1979-05-25 Procedimiento para preparar antibioticos de cefalosporina.

Country Status (13)

Country Link
AT (1) AT365597B (de)
AU (1) AU524692B2 (de)
CA (1) CA1130279A (de)
CH (1) CH646705A5 (de)
DE (1) DE2921344A1 (de)
DK (1) DK217079A (de)
ES (1) ES480920A1 (de)
FR (1) FR2426692A1 (de)
IE (1) IE49174B1 (de)
IT (1) IT1116187B (de)
NL (1) NL7904126A (de)
NZ (1) NZ190556A (de)
SE (1) SE438508B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE878514A (fr) * 1978-09-04 1980-02-29 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3-cephem-4-carboxylique a disubstitution en positions 3 et 7, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides

Also Published As

Publication number Publication date
AU524692B2 (en) 1982-09-30
FR2426692B1 (de) 1983-01-07
SE438508B (sv) 1985-04-22
AU4742179A (en) 1979-11-29
NL7904126A (nl) 1979-11-28
NZ190556A (en) 1982-05-25
FR2426692A1 (fr) 1979-12-21
DK217079A (da) 1979-11-27
ATA383679A (de) 1981-06-15
IE49174B1 (en) 1985-08-21
SE7904578L (sv) 1979-11-27
DE2921344A1 (de) 1979-12-06
IT1116187B (it) 1986-02-10
IE791026L (en) 1979-11-26
AT365597B (de) 1982-01-25
CH646705A5 (en) 1984-12-14
CA1130279A (en) 1982-08-24
IT7949180A0 (it) 1979-05-25

Similar Documents

Publication Publication Date Title
ES480990A1 (es) Un procedimiento para la preparacion de derivados acilados.
SE7908896L (sv) Cefalosporinforeningar
ES480920A1 (es) Procedimiento para preparar antibioticos de cefalosporina.
ES486023A1 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporina
SE7908895L (sv) Cefalosporinforeningar
YU158385A (en) Process for obtaining derivatives of 2-pyridine thioles
ZA793636B (en) Substituted 2-phenylamino-2-imidazolines,acid addition salts thereof,processes for their preparation,and pharmaceutical composition,and pharmaceutical compositions containing these compounds
ES8201993A1 (es) Un procedimiento para la preparacion de tiazoles
DE2962697D1 (en) Aminoglycosides derived from desoxystreptamin and their salts, their method of preparation and pharmaceutical compositions containing them
SE8303727L (sv) Cefalosporinantibiotika
SE7612960L (sv) Tienamycinderivat
ES8600636A1 (es) Procedimiento de preparacion de derivados de piperacina
IL96160A0 (en) Process for preparing(1r,2r)-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxides,the(1r,2r)-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxides thereby obtained and pharmaceutical compositions containing them
GB2001531A (en) Organic compounds
IL61253A (en) Nb-quaternary derivatives of 10-bromoajmaline and 10-bromoisoajmaline,their preparation and pharmaceutical compositions containing them
SE8306475L (sv) Cefalosporinantibiotika
FR2426466A1 (fr) Nouveaux antibiotiques du type cephalosporine et leur procede de preparation
IL61265A0 (en) Derivatives of 10-bromosandwicine and 10-bromoisosandwicine, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201